These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12108465)

  • 1. Cardiovascular risk factors in progressive renal disease.
    Harris KP
    Clin Med (Lond); 2002; 2(3):191-4. PubMed ID: 12108465
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease: a risk factor for cardiovascular disease.
    Wali RK; Henrich WL
    Cardiol Clin; 2005 Aug; 23(3):343-62. PubMed ID: 16084283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine in renal disease.
    Ducloux D; Motte G; Chalopin JM
    Clin Lab; 2000; 46(3-4):141-51. PubMed ID: 10791121
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease in chronic renal disease.
    Levey AS; Eknoyan G
    Nephrol Dial Transplant; 1999 Apr; 14(4):828-33. PubMed ID: 10328452
    [No Abstract]   [Full Text] [Related]  

  • 5. The link between bone and cardiovascular disease in CKD: new insights into pathogenesis and treatment.
    Cozzolino M; Ketteler M
    Int J Artif Organs; 2009 Feb; 32(2):65-6. PubMed ID: 19363776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):142-60, 187-235. PubMed ID: 15696904
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular disease in patients with chronic kidney disease.
    Wright J; Hutchison A
    Vasc Health Risk Manag; 2009; 5():713-22. PubMed ID: 19756163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.
    Agrawal V; Marinescu V; Agarwal M; McCullough PA
    Nat Rev Cardiol; 2009 Apr; 6(4):301-11. PubMed ID: 19352334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and management of cardiovascular disease in patients with chronic kidney disease.
    Bucharles SG; Varela AM; Barberato SH; Pecoits-Filho R
    J Bras Nefrol; 2010 Mar; 32(1):118-25. PubMed ID: 21448530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and chronic renal disease: a new paradigm.
    Sarnak MJ; Levey AS
    Am J Kidney Dis; 2000 Apr; 35(4 Suppl 1):S117-31. PubMed ID: 10766010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous cardiac and renal damage in a hypertensive population.
    Ruilope LM
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):301-2. PubMed ID: 19527319
    [No Abstract]   [Full Text] [Related]  

  • 12. The elderly with advanced chronic kidney disease.
    Abutaleb N
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):156-8; author reply 158-9. PubMed ID: 21196638
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension and future cardiovascular disease in pediatric renal transplant recipients.
    Flynn JT
    Pediatr Transplant; 2006 May; 10(3):276-8. PubMed ID: 16677348
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Curr Vasc Pharmacol; 2012 May; 10(3):374-7. PubMed ID: 22272896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic kidney disease. Better detect, slow its progression and cardiovascular risk, prepare for renal replacement therapy].
    Legendre C
    Rev Prat; 2012 Jan; 62(1):27-9. PubMed ID: 22335062
    [No Abstract]   [Full Text] [Related]  

  • 16. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?
    Rump LC; Amann K; Orth S; Ritz E
    Nephrol Dial Transplant; 2000 Nov; 15(11):1735-8. PubMed ID: 11071955
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.
    Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ
    Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengths and weaknesses of renal markers as risk factors and surrogate markers.
    Johnson KR
    Kidney Int; 2011 Jun; 79(12):1272-4. PubMed ID: 21625257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease as a potent risk modifier for CAD in diabetics.
    Fink JC
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):746-8. PubMed ID: 20633853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.